Movahedi, Mohammad, Bishop, D. Timothy, Bisgaard, Marie-Luise, Dunlop, Malcolm G., Ho, Judy W. C., Hodgson, Shirley V., Lindblom, Annika, Lubinski, Jan, Morrison, Patrick J., Murday, Victoria, Ramesar, Raj S., Side, Lucy, Macrae, Finlay, Scott, Rodney J., Thomas, Huw J. W., Vasen, Hans F., Burn, John, Mathers, John C., Mecklin, Jukka-Pekka, Moeslein, Gabriela, Olschwang, Sylviane, Eccles, Diana, Evans, D. Gareth, Maher, Eamonn R., Bertario, Lucio. American Society of Clinical Oncology; 2015. Obesity, aspirin, and risk of colorectal cancer in carriers of hereditary colorectal cancer: a prospective investigation in the CAPP2 study.

Kaput, Jim, Cotton, Richard G. H., Bapat, Bharati, Bernstein, Inge T., Bhak, Jong, Bleoo, Stacey L., Blöcker, Helmut, Brenner, Steven E., Burn, John, Bustamante, Mariona, Calzone, Rita, Scott, Rodney J., Hardman, Lauren, Watson, Michael, Aqeel, Aida I. Al, Al-Aama, Jumana Y., Al-Mulla, Fahd, Alonso, Santos, Aretz, Stefan, Auerbach, Arleen D.. John Wiley; 2009. Planning the Human Variome Project: the Spain report.

Hitchins, Megan, Williams, Rachel, Cheong, Kayfong, Halani, Nimita, Lin, Vita A.P., Packham, Deborah, Ku, Sue, Buckle, Andrew, Hawkins, Nicholas, Burn, John, Steven Gallinger, Jack Goldblattshort, Judy Kirk, Ian Tomlinson, Scott, Rodney, Spigelman, Allan, Catherine Suter, David Martin, Graeme Suthers, Robyn Ward. W.B. Saunders; 2005. MLH1 Germline Epimutations as a Factor in Hereditary Nonpolyposis Colorectal Cancer.

Burn, John, Gerdes, Anne-Marie, Bisgaard, Marie Louise, Dunlop, Malcolm G., Ho, Judy W. C., Hodgson, Shirley V., Lindblom, Annika, Lubinski, Jan, Morrison, Patrick J., Murday, Victoria, Ramesar, Raj, Side, Lucy, Macrae, Finlay, Scott, Rodney J., Thomas, Huw J. W., Vasen, Hans F., Barker, Gail, Crawford, Gillian, Elliott, Faye, Movahedi, Mohammad, Pylvanainen, Kirsi, Wijnen, Juul T., Fodde, Riccardo, Mecklin, Jukka-Pekka, Lynch, Henry T., Mathers, John C., Bishop, D. Timothy, Moeslein, Gabriela, Olschwang, Sylviane, Eccles, Diane, Evans, D. Gareth, Maher, Eamonn R., Bertario, Lucio. Lancet Publishing Group; 2011. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

Burn, John, Sheth, Harsh, Gerdes, Anne-Marie, Ho, Judy W. C., Lindblom, Annika, Morrison, Patrick J., Rashbass, Jem, Ramesar, Raj, Seppälä, Toni, Thomas, Huw J. W., Pylvänäinen, Kirsi, Borthwick, Gillian M., Elliott, Faye, Mathers, John C., Bishop, DT, Boussioutas, A, Brewer, C, Cook, J, Eccles, D, Ellis, A, Hodgson, SV, Lubinski, J, Maher, ER, Reed, Lynn, Porteous, ME, Sampson, J, Scott, RJ, Side, L, Macrae, Finlay, Mecklin, Jukka-Pekka, Möslein, Gabriela, McRonald, Fiona E., Bertario, Lucio, Evans, D. Gareth. Lancet; 2020. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial.

Burn, John, Bishop, Timothy, Bertario, Lucio, Jarvinen, Heikki J., Lindblom, Annika, Evans, D. Gareth, Lubinski, Jan, Morrison, Patrick J., Ho, Judy W. C., Vasen, Hans F. A., Side, Lucy, Thomas, Huw J. W., Mecklin, Jukka-Pekka, Scott, Rodney J., Dunlop, Malcolm, Barker, Gail, Elliott, Faye, Jass, Jeremy R., Fodde, Ricardo, Lynch, Henry T., Mathers, John C., Macrae, Finlay, Moslein, Gabriela, Olschwang, Sylviane, Bisgaard, Marie-Luise, Ramesar, Raj, Eccles, Diana, Maher, Eamonn R.. Massachusetts Medical Society; 2008. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.